SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-18-042499
Filing Date
2018-02-13
Accepted
2018-02-13 16:05:11
Documents
1
Group Members
KEVIN P. STARRMARK LEVINROBERT I. TEPPERTHIRD ROCK VENTURES GP II, L.P.THIRD ROCK VENTURES GP III, L.P.THIRD ROCK VENTURES III, L.P.TRV GP II, LLCTRV GP III, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d513053dsc13ga.htm SC 13G/A 193225
  Complete submission text file 0001193125-18-042499.txt   195044
Mailing Address 29 NEWBURY STREET 3RD FLOOR BOSTON MA 02116
Business Address 29 NEWBURY STREET 3RD FLOOR BOSTON MA 02116 617-585-2000
Third Rock Ventures II, L.P. (Filed by) CIK: 0001488495 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Subject) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88976 | Film No.: 18603252
SIC: 2834 Pharmaceutical Preparations